Post-approval studies (Phase 4)Study completedNCT04367831
What this trial is testing
Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19
Who this might be right for
COVID-19Venous ThrombosesArterial Thrombosis
Columbia University 94